By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Relmada Therapeutics 

  New York    U.S.A.
Phone: n/a Fax: n/a


Company News
Relmada Therapeutics Strengthens Its Board Of Directors With The Appointment Of Maged Shenouda And Paul Kelly 11/12/2015 7:56:00 AM
Relmada Therapeutics Responds To 13D Filing By Laidlaw 11/5/2015 7:38:52 AM
Relmada Therapeutics To Present At 14th Annual BIO Investor Forum 10/13/2015 9:59:37 AM
Relmada Therapeutics Announces Management Promotions 10/5/2015 7:23:51 AM
Relmada Therapeutics To Present At Aegis 2015 Growth Conference 10/2/2015 7:53:26 AM
Relmada Therapeutics To Present At Ladenburg Thalmann 2015 Healthcare Conference 9/24/2015 11:05:11 AM
Relmada Therapeutics Announces Issuance Of U.S. Patent Covering SECUREL - An Abuse-Deterrent, Extended-Release, Technology Platform For Opioids 9/9/2015 6:53:45 AM
Relmada Therapeutics To Participate In Two Upcoming Investor Conferences 9/2/2015 10:19:01 AM
Relmada Therapeutics Receives Health Canada Clearance To Commence Multiple Ascending Dose Study With Promising NMDA Receptor Antagonist 8/17/2015 6:28:11 AM
Relmada Therapeutics Announces Launch Of New Website And Corporate Communication Channels 8/12/2015 11:17:43 AM